SEC Form 4 · accession 0001209191-15-048056
ChemoCentryx, Inc. · CCXI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Geoffrey M. Parker
Director
Period of report
May 27, 2015
Accepted (ET)
May 29, 2015 · 5:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001340652
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | May 27, 2015 | S | 13,513 | $7.5124 | D | 13,514 | D | |
| Common Stock | holding | — | — | — | 19,600 | I | By Geoffrey M Parker and Jill Gofen Parker Trustees of Geoffrey M Parker and Jill G Parker Revocable | |
| Common Stock | holding | — | — | — | 5,000 | I | By Delaware Charter Guarantee & Trust Company, Trustee FBO Mr. Geoffrey Monroe Parker IRA |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person to cover estimated taxes due upon vesting of restricted stock units.
- F2Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $7.26 to $7.63 per share, inclusive. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.